QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobeGlobeNewsWire • 06/05/24
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal careGlobeNewsWire • 06/03/24
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicineGlobeNewsWire • 05/29/24
Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 05/29/24
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision supportGlobeNewsWire • 05/14/24
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate resultsGlobeNewsWire • 05/13/24
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsGlobeNewsWire • 05/07/24
International Markets and Qiagen (QGEN): A Deep Dive for InvestorsZacks Investment Research • 05/06/24
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsGlobeNewsWire • 05/02/24
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceGlobeNewsWire • 04/29/24
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceGlobeNewsWire • 04/24/24
Unveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 04/24/24